During Q4 2018 the big money sentiment increased to 0.89. That’s change of 0.05, from 2018Q3’s 0.84. 24 investors sold all, 52 reduced holdings as Neenah, Inc. ratio is positive. 49 increased holdings while 19 funds took holdings. Funds hold 14.90 million shares thus 1.97% more from 2018Q3’s 14.61 million shares.
Fincl Bank Of America De holds 0% or 206,719 shs. Tiaa Cref Inv Limited Liability Company accumulated 31,871 shs. Advisors Cap Mgmt Ltd Llc holds 0.03% or 6,609 shs. Northwestern Mutual Wealth Management, Wisconsin-based fund reported 9 shs. Blackrock Inc reported 2.44 million shs. Assetmark Incorporated accumulated 141 shs. Aperio Gru Limited Co owns 14,296 shs. 924,005 were reported by Macquarie Group Ltd. Federated Investors Pa invested in 50,301 shs or 0.01% of the stock. The New Jersey-based Lord Abbett & Ltd Liability has invested 0.05% in Neenah, Inc. (NYSE:NP). Fmr Limited Liability Corporation reported 0% of its capital in Neenah, Inc. (NYSE:NP). Baskin Services invested in 1.26% or 99,424 shs. Smithfield Trust Co invested in 0% or 500 shs. Timber Creek Cap Ltd Liability Corp invested in 0.01% or 149 shs. Reilly Ltd Liability Corporation reported 0% of its capital in Neenah, Inc. (NYSE:NP).
Neenah, Inc. had 3 selling transactions and 0 insider buys since January 2, 2019. This’s net activity of $392,029. Another trade for 1,866 shs valued at $121,290 was sold by Duncan Matthew L. $66,918 worth of Neenah, Inc. (NYSE:NP) was sold by Benz Noah Samuel.
Investors wait Neenah, Inc. (NYSE:NP)’s quarterly earnings on May, 8., RTT reports. The earnings per share diference is $0.28 or 26.92 % down from last years number. Previous year: $1.04; Analysts forcast: $0.76. This could hit $12.81M profit for NP assuming the current $0.76 earnings per share will become reality. After $0.53 earnings per share was reported previous quarter, analysts now see EPS growth of 43.40 % for Neenah, Inc.. NP touched $65.96 during the last trading session after $0.57 change.Neenah, Inc. has volume of 24,044 shares. Since April 16, 2018 NP has declined 11.96% and is downtrending. NP underperformed by 16.33% the S&P 500.
Neenah, Inc. produces and sells technical products, and fine paper and packaging products worldwide.The firm is valued at $1.11 billion. The company's Technical Products segment provides filtration media for transportation, water, and other filtration markets; saturated and unsaturated crepe, and flat paper tapes to manufacturers; coated lightweight abrasive paper for use in the automotive, construction, metal, and woodworking industries; label and tag products for variable and digital printing; latex saturated and coated papers; premask, medical packaging, image transfer, publishing, and security papers; and other specialty products, including clean room papers, durable printing papers, release papers, and furniture backers.The P/E ratio is 31.08. The Company’s Fine Paper and Packaging segment makes and sells writing, text, cover, and specialty papers and envelopes used in corporate identity packages, advertising collateral, premium labels and packaging, and wide format applications.
More recent Neenah, Inc. (NYSE:NP) news were posted by Businesswire.com, Seekingalpha.com and Seekingalpha.com. The first one has “Results of Phase 3 Trial Evaluating Merck’s ZERBAXA® (ceftolozane and tazobactam) versus Meropenem for Treatment of Adult Patients with Ventilated Nosocomial Pneumonia (VNP) to be Presented at ECCMID 2019 – Business Wire” as a title and was posted on April 13, 2019. The next is “Neenah Paper, Inc. (NP) CEO John O’Donnell on Q3 2018 Results – Earnings Call Transcript – Seeking Alpha” on November 14, 2018. And last was posted on April 15, 2019, called “Merck’s Zerbaxa on par with meropenem in late-stage pneumonia study – Seeking Alpha”.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.